Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Biora Therapeutics (BIOR)
NASDAQ:BIOR
Biora Therapeutics (BIOR) Stock Price & Analysis
1,036 Followers
BIOR Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.61 - $6.70
Previous Close$0.62
Volume244.17K
Average Volume (3M)463.61K
Market Cap
$22.25M
Enterprise Value$102.65M
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$80.40M
Price to Earnings (P/E)>-0.1
Beta1.69
Next Earnings
May 08, 2024EPS Estimate
-$0.45Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-8.57
Shares Outstanding30,313,428
10 Day Avg. Volume494,145
30 Day Avg. Volume463,614
Standard Deviation0.36
R-Squared0.02
Alpha-0.07
Financial Highlights & Ratios
Price to Book (P/B)-0.16
Price to Sales (P/S)61.62
Price to Cash Flow (P/CF)-0.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue5.70K
Enterprise Value/Gross Profit336.55
Enterprise Value/Ebitda-0.96
Forecast
1Y Price Target
$15.00Price Target Upside2315.46% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Biora Therapeutics News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
BIOR FAQ
What was Biora Therapeutics’s price range in the past 12 months?
Biora Therapeutics lowest stock price was $0.61 and its highest was $6.70 in the past 12 months.
What is Biora Therapeutics’s market cap?
Currently, no data Available
When is Biora Therapeutics’s upcoming earnings report date?
Biora Therapeutics’s upcoming earnings report date is May 08, 2024 which is in 19 days.
How were Biora Therapeutics’s earnings last quarter?
Biora Therapeutics released its earnings results on Mar 26, 2024. The company reported -$0.625 earnings per share for the quarter, missing the consensus estimate of -$0.595 by -$0.03.
Is Biora Therapeutics overvalued?
According to Wall Street analysts Biora Therapeutics’s price is currently Undervalued.
Does Biora Therapeutics pay dividends?
Biora Therapeutics does not currently pay dividends.
What is Biora Therapeutics’s EPS estimate?
Biora Therapeutics’s EPS estimate is -$0.45.
How many shares outstanding does Biora Therapeutics have?
Biora Therapeutics has 35,883,842 shares outstanding.
What happened to Biora Therapeutics’s price movement after its last earnings report?
Biora Therapeutics reported an EPS of -$0.625 in its last earnings report, missing expectations of -$0.595. Following the earnings report the stock price went down -12.03%.
Which hedge fund is a major shareholder of Biora Therapeutics?
Currently, no hedge funds are holding shares in BIOR
---
Biora Therapeutics Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$15.00 (2315.46% Upside)
$15.00 (2315.46% Upside)
Blogger Sentiment
Bullish
BIOR Sentiment 100%
Sector Average 70%
Sector Average 70%
Crowd Wisdom
Negative
Last 7 Days ▲ 0.8%
Last 30 Days ▼ 2.0%
Last 30 Days ▼ 2.0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-76.15%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-41.68%
Trailing 12-Months
Company Description
Biora Therapeutics
Progenity Inc is a biotechnology company. It is engaged in developing and commercializing molecular testing products. The company is translating innovation into precision medicine through diagnostic and therapeutic development platforms based on genomics, proteomics, and microbiomics. The firm generates its revenue from molecular laboratory tests, principally from the sale of Innatal, Preparent, and pathology molecular testing.
---
BIOR Earnings Call
Q4 2024
0:00 / 0:00
---
BIOR Stock 12 Months Forecast
Average Price Target
$15.00
▲(2315.46% Upside)
Technical Analysis
Bioxcel Therapeutics
―
Aldeyra Therapeutics
―
Karyopharm Therapeutics
―
Crispr Therapeutics AG
―
Best Analysts Covering BIOR
1 Year
1 Year Success Rate
0/10 ratings generated profit
1 Year Average Return
-64.22%
reiterated a buy rating 11 days ago
Copying Joseph Pantginis's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -64.22% per trade.
---